The 20 Best Supranuclear Ophthalmoplegia Doctors near San Francisco, CA

Dr. Adam Boxer is a neurologist at the UCSF Memory and Aging Center who specializes in Alzheimer's disease, frontotemporal dementia and atypical parkinsonism – in particular, corticobasal degeneration and progressive supranuclear palsy. Boxer obtained his medical and doctoral degrees as part of the Medical Scientist Training Program at New York University School of Medicine, a program funded by the National Institutes of Health. He completed a residency in neurology at Stanford University Medical Center and a fellowship in behavioral neurology at UCSF. Boxer directs the clinical neurology research unit for the Sandler Neurosciences Center at Mission Bay, as well as the clinical trials program for Alzheimer's disease and frontotemporal dementia at the Memory and Aging Center. Boxer received the Edwin Boldrey Award from the San Francisco Neurological Society in 2002 for basic research in neurological disease, the 2005 John Douglas French Alzheimer's Foundation Alzheimer's Award and a 2009 Hellman Family Foundation fellowship. Dr. Boxer is rated as an Elite provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Progressive Supranuclear Palsy, Progressive Supranuclear Palsy Atypical, Supranuclear Ophthalmoplegia, and Corticobasal Degeneration.

Arshia Sadreddin is a Neurologist in San Francisco, California. Dr. Sadreddin is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Progressive Supranuclear Palsy Atypical, Supranuclear Ocular Palsy, and Deep Brain Stimulation. Dr. Sadreddin is currently accepting new patients.

Dr. William Seeley works at the UCSF Memory and Aging Center. He cares for patients with neurodegenerative diseases, such as Alzheimer's disease and frontotemporal dementia (FTD). In 2011, Seeley was named a MacArthur Foundation Fellow for his research on understanding FTD and other neurodegenerative diseases. His research focuses on why dementias target specific nerve cell populations. The goal is to discover what makes brain tissues susceptible or resistant to degeneration and to translate these findings into new treatments. Seeley earned his medical degree at UCSF, where he also completed an internship in internal medicine. He completed a residency in neurology at the Massachusetts General and Brigham and Women's hospitals in Boston, followed by a fellowship in behavioral neurology at UCSF. Dr. Seeley is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Frontotemporal Dementia, Dementia, Primary Progressive Aphasia, and Alzheimer's Disease.

Dr. Ian Bledsoe is a neurologist who cares for patients who have Parkinson's disease, tremors, ataxia, dystonia and other movement disorders. His treatments include medications, botulinum toxin injections and a surgical procedure called deep brain stimulation. Bledsoe has a special interest in dystonia, a disorder that causes involuntary movements, cramps and abnormal postures. He particularly focuses on a form of the condition that affects musicians and other patients whose work requires repetitive movements. Bledsoe's research interests include finding better treatments for dystonia and using neuroimaging – advanced image-producing technologies applied to the nervous system – to improve understanding of what causes the condition. He has also used neuroimaging to study cognitive problems associated with Parkinson's disease. Bledsoe received his medical degree from the University of Pittsburgh School of Medicine. He then completed a residency in neurology as well as a fellowship in clinical neurophysiology and electromyography at Stanford Health Care. At Rush University Medical Center in Chicago, he also completed a fellowship in movement disorders and a master's degree in clinical research. Bledsoe is a member of the American Academy of Neurology, International Parkinson and Movement Disorder Society, and Performing Arts Medicine Association. Before attending medical school, Bledsoe earned a bachelor's degree in violin performance at Northwestern University. He continues to play and perform in his free time. Dr. Bledsoe is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Drug Induced Dyskinesia, Movement Disorders, Parkinson's Disease, Familial Paroxysmal Nonkinesigenic Dyskinesia, and Deep Brain Stimulation.

Melanie Wu is a Neurologist in San Francisco, California. Dr. Wu is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Essential Tremor, Tardive Dyskinesia, Secondary Parkinsonism, and Multiple System Atrophy. Dr. Wu is currently accepting new patients.

Armen Moughamian is a Neurologist in San Francisco, California. Dr. Moughamian is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Cerebellar Degeneration, Primary Progressive Aphasia, Frontotemporal Dementia, and Lewy Body Dementia (LBD). Dr. Moughamian is currently accepting new patients.

Richard Tsai is a Neurologist in San Francisco, California. Dr. Tsai is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ophthalmoplegia, and Brown Syndrome.

Howard Rosen is a Pain Medicine provider in San Francisco, California. Dr. Rosen is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Frontotemporal Dementia, Dementia, Primary Progressive Aphasia, and Corticobasal Degeneration.

Maria Tartaglia is a Neurologist in San Francisco, California. Dr. Tartaglia is rated as a Distinguished provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Frontotemporal Dementia, Dementia, Progressive Supranuclear Palsy, and Progressive Supranuclear Palsy Atypical.

Dr. Julio C. Rojas is a neurologist who specializes in dementia, caring for patients with cognitive difficulties or behavioral changes resulting from conditions including Alzheimer's disease, Lewy body dementia (a form of dementia that causes cognitive defects and Parkinson's-like symptoms), frontotemporal dementia (a common cause of dementia in younger adults that features behavioral changes) and progressive supranuclear palsy (a condition affecting movement and behavior in older adults). With particular expertise in managing difficult behaviors in dementia, he creates care plans to equip patients and their families with the necessary tools for achieving their best-possible quality of life. In his research, Rojas looks for blood tests that could be used to diagnose dementia. He also works on developing novel treatments to prevent or slow neurological degeneration and cognitive impairment. His research is funded by the National Institute on Aging. Rojas earned his medical degree from the School of Medicine and Health Sciences of the Tecnológico de Monterrey in Mexico. He earned a doctorate in neuroscience from the University of Texas at Austin. He completed a residency in neurology at the University of Texas Southwestern Medical Center and a fellowship in behavioral neurology at UCSF. A native of Mexico City, Rojas conducts patient evaluations in both English and Spanish. He strives to improve access to dementia care for Hispanic communities in the United States. For the UCSF Memory and Aging Center, he co-chairs a task force that works to improve management of behavioral symptoms for the center's patients with dementia. He also participates in UCSF committees on ethics and on diversity and inclusion. Dr. Rojas is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Supranuclear Ocular Palsy, Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy Atypical, and Progressive Supranuclear Palsy.

Dr. Salvatore Spina is a behavioral neurologist who cares for patients with degenerative, vascular, inflammatory and autoimmune conditions that cause problems with memory, thinking or language, or personality changes. This includes Alzheimer's disease, Parkinson's disease, Lewy body disease, frontotemporal dementia and various conditions that cause aphasia, which is loss of the ability to speak or to understand speech. He also treats patients with movement disorders accompanied by cognitive and behavioral symptoms, including those affected by corticobasal syndrome, progressive supranuclear palsy and motor neuron diseases. Spina's research investigates the relationship between cognitive changes and behavioral changes in patients with Alzheimer's disease, dementia, Parkinson's disease and other conditions that destroy the cells for such voluntary movements as walking, speaking and swallowing. He specifically examines inflammation in the brain, lost neurons and synapses, and brain changes that indicate disease progression. His study tools include evaluation of neurological symptoms, results from neuropsychological testing, neuroimaging with magnetic resonance imaging and positron emission tomography, and checking genetic or other kinds of biomarkers (measurable substances that can indicate disease). He is a member of the UCSF Neurodegenerative Disease Brain Bank, which uses donated nervous system tissue to further scientific understanding of these conditions. Spina earned his medical degree from the University of Catania. He completed a residency in neurology at the University of Siena, where he also earned a doctoral degree studying how neurodegenerative diseases arise when nerve cells lose their structure or function. He then completed a residency in neurology at Indiana University and a fellowship in behavioral neurology at UCSF. Spina is a member of the American Board of Psychiatry and Neurology, American Academy of Neurology and American Association of Neuropathologists. As a researcher, he has been honored by the European Confederation of Neuropathological Societies and Hellenic Society of Neuropathology. Dr. Spina is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Dementia, Corticobasal Degeneration, Alzheimer's Disease, and Frontotemporal Dementia.

Dr. Chadwick Christine is a neurologist at the Parkinson's Disease and Movement Disorders Clinic. He specializes in the diagnosis and treatment of Parkinson's disease and other movement disorders. Christine is a graduate of Cornell University, where he earned a bachelor of arts degree in physics and English, as well as his medical degree. He completed a residency in neurology and a postdoctoral fellowship at UCSF, focusing on the research of synaptic plasticity. Dr. Christine is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Parkinson's Disease, Movement Disorders, Vitamin B12 Deficiency Anemia, and Essential Tremor.

Dr. Beth Griffiths is an internal medicine specialist who provides primary and urgent care to adults. She especially enjoys helping her patients make lifestyle changes that will allow them to meet their health goals. Griffiths is passionate about the full spectrum of health care advocacy, from supporting individual patients to working for policy changes that would improve the health of all Americans. She currently serves as director of health care advocacy for the UCSF Division of General Internal Medicine and is involved in developing and evaluating efforts to better educate students, residents and faculty on health care policy and advocacy. Griffiths earned her master's degree in public health at Harvard University's T.H. Chan School of Public Health. She earned her medical degree at the University of California, San Diego, and completed a residency in internal medicine, with a focus on primary care, at UCSF. Prior to attending medical school, Griffiths worked on health and human services legislation in both the California state legislature and the U.S. House of Representatives. She has held leadership roles in the California Medical Association and American Medical Association. She is a member of the Society of General Internal Medicine, San Francisco Marin Medical Society, American Medical Association, California Medical Association and San Diego County Medical Society. In her free time, Griffiths enjoys cooking with fresh produce from the farmers market, traveling up and down the West Coast, reading The New York Times, and spending time with family and friends. Dr. Griffiths is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Progressive Supranuclear Palsy Atypical, Progressive Supranuclear Palsy, Supranuclear Ocular Palsy, and Supranuclear Ophthalmoplegia.

Lawren Vandevrede is an Internal Medicine provider in San Francisco, California. Dr. Vandevrede is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Corticobasal Degeneration, Dementia, Frontotemporal Dementia, and Alzheimer's Disease.

Peter Ljubenkov is a Neurologist in San Francisco, California. Dr. Ljubenkov is rated as an Advanced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Frontotemporal Dementia, Dementia, Corticobasal Degeneration, and Lewy Body Dementia (LBD).

Dr. Zachary Miller is a neurologist who specializes in caring for patients suffering from cognitive decline or dementia, including such conditions as Alzheimer's disease, frontotemporal dementia and corticobasal degeneration. In his research, Miller is particularly interested in identifying early risk factors for cognitive decline. He also studies the enhanced creativity and visual function that sometimes occurs in neurodegenerative disease. Miller earned his medical degree at the University of Pittsburgh. He completed a residency in neurology at the University of Washington, followed by a fellowship at the UCSF Memory and Aging Center. Miller is a clinical instructor in neurology at UCSF. He is a member of the American Academy of Neurology. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Cerebellar Degeneration, Primary Progressive Aphasia, Frontotemporal Dementia, and Progressive Supranuclear Palsy.

Caroline Tanner is a Neurologist in San Francisco, California. Dr. Tanner is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, Tardive Dyskinesia, and Deep Brain Stimulation. Dr. Tanner is currently accepting new patients.

Dr. Ethan G. Brown is a neurologist who primarily cares for adults with movement disorders, including Parkinson's disease, other types of parkinsonism, ataxia, dystonia, tremor and related conditions. He focuses on diagnosing and managing movement disorders through lifestyle changes and medications, as well as treatment with botulinum toxin (Botox). He also works with a team of other specialists to help manage deep brain stimulation and other surgical therapies. In research, Brown is interested in characterizing the earliest stages – or prodromal stage – of Parkinson's disease and related movement disorders. His projects involve identifying risk factors for these conditions and finding methods that facilitate their earliest possible diagnosis. Through a better understanding of prodromal disease, he hopes to enable earlier symptom treatment and biomarker identification (finding measurable indications of disease) and also to advance investigations of new treatments. Brown is also interested in environmental exposures that may be related to the development of Parkinson's disease or its progression. He is studying how changes in the gut microbiome (intestinal bacteria), among other factors, may contribute to Parkinson's disease symptoms, impact disease progression, or affect how drugs are transformed in the body. He is conducting a clinical trial (a study using human volunteers) to explore whether manipulating the gut microbiome can ease symptoms in people with Parkinson's disease. Brown earned his medical degree at Weill Cornell Medical College. He completed a residency in neurology and a fellowship in movement disorders at UCSF. He is a member of the American Academy of Neurology and International Parkinson and Movement Disorder Society. In his free time, Brown enjoys hiking, biking and being with his family. Dr. Brown is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Movement Disorders, Parkinson's Disease, Drug Induced Dyskinesia, and Corticobasal Degeneration.

Rafael Zuzuárregui is a neurologist who cares for patients with Parkinson's disease and other movement disorders. He specializes in using deep brain stimulation (electrodes implanted in the brain to regulate abnormal activity) and botulinum toxin therapy (injections that can relieve muscle contractions). He is also interested in diagnosing and treating rapid eye movement (REM) sleep behavior disorder (a condition in which patients physically act out vivid dreams). Zuzuárregui's research focuses on the overlap between movement disorders, such as Parkinson's disease, and sleep disorders. He is particularly interested in how deep brain stimulation can help improve sleep in patients with these disorders. He also studies issues related to medical education. At Boston University School of Medicine, Zuzuárregui earned his medical degree; completed a residency in neurology, serving as chief resident; and completed a fellowship in movement disorders. He then completed a fellowship in sleep disorders at Stanford University School of Medicine. He is a member of the American Academy of Neurology and International Parkinson and Movement Disorder Society. Dr. Zuzuarregui is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. His top areas of expertise are Parkinson's Disease, Movement Disorders, Secondary Parkinsonism, and REM Behavior Disorder.

Dr. Maria Luisa Gorno-Tempini is a neurologist at the UCSF Memory and Aging Center. Her goal in patient care is to use state-of the-art cognitive and imaging techniques to diagnose and treat neurological disorders. She places a particular emphasis on managing dementia and neurodegenerative disorders. Gorno-Tempini's main research interest is progressive aphasia, impaired ability to speak or understand language. Gorno-Tempini completed her medical degree and specialty training in neurology in Italy, with a focus on behavioral neurology. She worked for three years in the Functional Imaging Laboratory at University College London, where she also earned a doctorate in imaging neuroscience. Dr. Gorno is rated as an Experienced provider by MediFind in the treatment of Supranuclear Ophthalmoplegia. Her top areas of expertise are Primary Progressive Aphasia, Dementia, Frontotemporal Dementia, and Developmental Reading Disorder.